CR11441A - Producto de dispersion solida que contiene un compuesto a base de n-aril urea - Google Patents
Producto de dispersion solida que contiene un compuesto a base de n-aril ureaInfo
- Publication number
- CR11441A CR11441A CR11441A CR11441A CR11441A CR 11441 A CR11441 A CR 11441A CR 11441 A CR11441 A CR 11441A CR 11441 A CR11441 A CR 11441A CR 11441 A CR11441 A CR 11441A
- Authority
- CR
- Costa Rica
- Prior art keywords
- urea
- aril
- based compound
- product containing
- solid dispersion
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Un producto que comprende al menos un agente farmaceuticamente activo a base de N-aril urea o un agente de estructura relacionada que es obtenido mediante a) la preparacion de una mezcla liquida que contiene el al menos un agente activo
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99961307P | 2007-10-19 | 2007-10-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR11441A true CR11441A (es) | 2010-10-25 |
Family
ID=40089072
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR11441A CR11441A (es) | 2007-10-19 | 2010-05-19 | Producto de dispersion solida que contiene un compuesto a base de n-aril urea |
Country Status (23)
Country | Link |
---|---|
US (1) | US20090143423A1 (es) |
EP (1) | EP2197426A2 (es) |
JP (1) | JP2011500647A (es) |
KR (1) | KR20100090689A (es) |
CN (1) | CN101827585A (es) |
AR (1) | AR068916A1 (es) |
AU (1) | AU2008313620A1 (es) |
BR (1) | BRPI0818339A2 (es) |
CA (1) | CA2699335A1 (es) |
CL (1) | CL2008003092A1 (es) |
CO (1) | CO6270303A2 (es) |
CR (1) | CR11441A (es) |
DO (1) | DOP2010000114A (es) |
EC (1) | ECSP10010184A (es) |
GT (1) | GT201000095A (es) |
MX (1) | MX2010004292A (es) |
PE (1) | PE20091041A1 (es) |
RU (1) | RU2010119924A (es) |
TW (1) | TW200922549A (es) |
UA (1) | UA100866C2 (es) |
UY (1) | UY31406A1 (es) |
WO (1) | WO2009050289A2 (es) |
ZA (1) | ZA201002130B (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102186836A (zh) * | 2008-10-17 | 2011-09-14 | 雅培制药有限公司 | Trpv1拮抗剂 |
CN102245587A (zh) * | 2008-10-17 | 2011-11-16 | 雅培制药有限公司 | Trpv1拮抗剂 |
US20100210682A1 (en) * | 2009-02-19 | 2010-08-19 | Abbott Laboratories | Repeated Dosing of TRPV1 Antagonists |
US20120168987A1 (en) * | 2009-09-18 | 2012-07-05 | Basf Se | Method For Producing Preparations Of Substances With Low Solubility In Water |
US10463739B2 (en) | 2010-12-23 | 2019-11-05 | AbbVie Deutschland GmbH & Co. KG | Solid retard formulations based on solid dispersions |
MX2013007959A (es) * | 2011-01-10 | 2013-12-06 | Celgene Corp | Formas farmaceuticas orales de amida {2-[(1s)-1-(3-etoxi-4-metoxi- fenil]-2-metansulfonil-etil]-3-oxo-2,,3-dihidro-1h-isoindol -4-il}-del acido ciclopropancarboxilico. |
US9034832B2 (en) | 2011-12-29 | 2015-05-19 | Abbvie Inc. | Solid compositions |
CA2857339C (en) * | 2011-12-29 | 2015-11-17 | Abbvie Inc. | Solid compositions comprising an hcv inhibitor |
TW201431570A (zh) | 2012-11-22 | 2014-08-16 | Ucb Pharma Gmbh | 用於經皮投服羅替戈汀(Rotigotine)之多天式貼片 |
ES2771458T3 (es) | 2013-01-31 | 2020-07-06 | Gilead Pharmasset Llc | Formulación de combinación de dos compuestos antivirales |
JP6130585B2 (ja) | 2013-03-15 | 2017-05-17 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 無定形状態のhcv阻害薬の固体経口投薬製剤 |
US10046151B2 (en) | 2013-07-03 | 2018-08-14 | Lts Lohmann Therapie-Systeme, Ag | Transdermal therapeutic system with electronic component |
PL3650014T3 (pl) | 2013-08-27 | 2022-01-31 | Gilead Pharmasset Llc | Preparat złożony dwóch związków przeciwwirusowych |
WO2015177212A1 (en) | 2014-05-20 | 2015-11-26 | Lts Lohmann Therapie-Systeme Ag | Transdermal delivery system including an interface mediator |
JP6895755B2 (ja) | 2014-05-20 | 2021-06-30 | エルテーエス ローマン テラピー−ジステーメ アーゲー | 経皮送達システムにおける活性薬剤の放出を調節するための方法 |
ES2924899T3 (es) | 2014-05-20 | 2022-10-11 | Lts Lohmann Therapie Systeme Ag | Sistema de administración transdérmica que contiene rotigotina |
CA3039767C (en) * | 2015-12-22 | 2023-11-14 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Compositions and methods for treatment, amelioration, and prevention of anesthesia-induced hypothermia |
JP7425794B2 (ja) * | 2018-10-30 | 2024-01-31 | ペロトン セラピューティクス, インコーポレイテッド | 置換されたインダンを含む固体分散体及び医薬組成物並びにそれの製造方法及び使用 |
JP6830569B1 (ja) | 2019-08-23 | 2021-02-17 | 持田製薬株式会社 | ヘテロシクリデンアセトアミド誘導体の製造方法 |
WO2021039023A1 (ja) | 2019-08-23 | 2021-03-04 | 持田製薬株式会社 | ヘテロシクリデンアセトアミド誘導体の製造方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5362878A (en) * | 1991-03-21 | 1994-11-08 | Pfizer Inc. | Intermediates for making N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase (ACAT) |
KR950701621A (ko) * | 1992-05-28 | 1995-04-28 | 알렌 제이. 스피겔 | 아실 조효소a : 콜레스테롤 아실 전이효소(acat)의 억제제로서 신규한 n- 아릴 및 n- 헤테로아릴우레아 유도체(new n-aryl and n-heteroarylurea derivatives as inhibitors of acyl coenzyme a : cholesterol acyl transferase(acat) |
WO2000003753A2 (en) * | 1998-07-14 | 2000-01-27 | Em Industries, Inc. | Microdisperse drug delivery systems |
US7015233B2 (en) * | 2003-06-12 | 2006-03-21 | Abbott Laboratories | Fused compounds that inhibit vanilloid subtype 1 (VR1) receptor |
WO2005123076A2 (en) * | 2004-06-08 | 2005-12-29 | Vertex Pharmaceuticals, Inc. | Pharmaceutical compositions |
EP1796642B1 (en) * | 2004-08-27 | 2008-05-21 | Bayer Pharmaceuticals Corporation | Pharmaceutical compositions in the form of solid dispersions for the treatment of cancer |
WO2006113631A2 (en) * | 2005-04-18 | 2006-10-26 | Rubicon Research Pvt. Ltd. | Bioenhanced compositions |
KR100715355B1 (ko) * | 2005-09-30 | 2007-05-07 | 주식회사유한양행 | 프란루카스트를 함유하는 분무-건조 과립 및 그의 제조방법 |
US20070104780A1 (en) * | 2005-10-25 | 2007-05-10 | Lipari John M | Formulation comprising a drug of low water solubility and method of use thereof |
WO2007066189A2 (en) * | 2005-12-09 | 2007-06-14 | Pfizer Products Inc. | Salts, prodrugs and formulations of 1-[5-(4-amino-7-isopropyl-7h-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2-methoxy-phenyl]-3-(2,4-dichloro-phenyl)-urea |
US7745448B2 (en) * | 2005-12-28 | 2010-06-29 | Abbott Laboratories Inc. | Crystalline N-(4-(4-aminothieno[2,3-d]pyrimidin-5-yl)phenyl)-N′-(2-fluoro-5-(trifluoromethyl)phenyl)urea ethanolate |
KR101418267B1 (ko) * | 2006-02-09 | 2014-07-11 | 머크 샤프 앤드 돔 코포레이션 | Cetp 억제제의 중합체 제형 |
-
2008
- 2008-10-17 KR KR1020107010874A patent/KR20100090689A/ko not_active Application Discontinuation
- 2008-10-17 BR BRPI0818339 patent/BRPI0818339A2/pt not_active IP Right Cessation
- 2008-10-17 PE PE2008001785A patent/PE20091041A1/es not_active Application Discontinuation
- 2008-10-17 US US12/253,499 patent/US20090143423A1/en not_active Abandoned
- 2008-10-17 EP EP08840773A patent/EP2197426A2/en not_active Withdrawn
- 2008-10-17 UA UAA201006030A patent/UA100866C2/ru unknown
- 2008-10-17 CA CA2699335A patent/CA2699335A1/en not_active Abandoned
- 2008-10-17 AU AU2008313620A patent/AU2008313620A1/en not_active Abandoned
- 2008-10-17 WO PCT/EP2008/064073 patent/WO2009050289A2/en active Application Filing
- 2008-10-17 CN CN200880112161A patent/CN101827585A/zh active Pending
- 2008-10-17 CL CL2008003092A patent/CL2008003092A1/es unknown
- 2008-10-17 TW TW097140229A patent/TW200922549A/zh unknown
- 2008-10-17 AR ARP080104542A patent/AR068916A1/es not_active Application Discontinuation
- 2008-10-17 JP JP2010529406A patent/JP2011500647A/ja active Pending
- 2008-10-17 MX MX2010004292A patent/MX2010004292A/es not_active Application Discontinuation
- 2008-10-17 RU RU2010119924/15A patent/RU2010119924A/ru not_active Application Discontinuation
- 2008-10-17 UY UY31406A patent/UY31406A1/es not_active Application Discontinuation
-
2010
- 2010-03-25 ZA ZA2010/02130A patent/ZA201002130B/en unknown
- 2010-04-15 GT GT201000095A patent/GT201000095A/es unknown
- 2010-04-16 DO DO2010000114A patent/DOP2010000114A/es unknown
- 2010-04-27 CO CO10049270A patent/CO6270303A2/es not_active Application Discontinuation
- 2010-05-17 EC EC2010010184A patent/ECSP10010184A/es unknown
- 2010-05-19 CR CR11441A patent/CR11441A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
UY31406A1 (es) | 2009-05-29 |
GT201000095A (es) | 2012-04-03 |
MX2010004292A (es) | 2010-08-02 |
CO6270303A2 (es) | 2011-04-20 |
RU2010119924A (ru) | 2011-11-27 |
WO2009050289A2 (en) | 2009-04-23 |
DOP2010000114A (es) | 2010-05-15 |
KR20100090689A (ko) | 2010-08-16 |
ZA201002130B (en) | 2011-11-30 |
BRPI0818339A2 (pt) | 2015-04-22 |
WO2009050289A3 (en) | 2010-03-25 |
CL2008003092A1 (es) | 2009-11-27 |
AR068916A1 (es) | 2009-12-16 |
CA2699335A1 (en) | 2009-04-23 |
AU2008313620A1 (en) | 2009-04-23 |
JP2011500647A (ja) | 2011-01-06 |
CN101827585A (zh) | 2010-09-08 |
US20090143423A1 (en) | 2009-06-04 |
PE20091041A1 (es) | 2009-08-22 |
TW200922549A (en) | 2009-06-01 |
ECSP10010184A (es) | 2010-06-29 |
EP2197426A2 (en) | 2010-06-23 |
UA100866C2 (ru) | 2013-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR11441A (es) | Producto de dispersion solida que contiene un compuesto a base de n-aril urea | |
CU20060153A7 (es) | Nueva forma cristalina v de agomelatina, procedimiento para su preparación y composiciones farmacéuticas que las contienen | |
CL2015001959A1 (es) | (divisional solicitud 1567-2013) combinaciones de principios activos que comprenden piridiletilbenzamidas y otros principios activos | |
EA200971081A1 (ru) | Пуриновые производные и их применение в качестве модуляторов толл-подобного рецептора 7 | |
AU2012259422A8 (en) | Solid forms of a pharmaceutically active substance | |
AR059350A1 (es) | Formulacion farmaceutica para aerosoles con dos o mas principios activos y al menos una sustancia tensioactiva | |
WO2010041141A3 (en) | Oil-based foamable carriers and formulations | |
MX2011006527A (es) | Agentes medicinales unidos a dipeptido. | |
UA108641C2 (uk) | Паразитицидна композиція, яка містить чотири активних агенти, та спосіб її застосування | |
CR20110110A (es) | Composicion farmaceutica | |
BR112014011609A2 (pt) | material de distribuição de fármaco polimérico, método para produção do mesmo, e método para distribuição de uma composição de distribuição de fármaco | |
DE602005025493D1 (de) | Entzündungshemmende wirkstoffe | |
GT200500349A (es) | Formulaciones de benzoxazoles substituidos | |
WO2010047592A3 (en) | Preservation mixture and use thereof | |
CR11442A (es) | Producto de dispersion solida de drogas basadas en n-aril urea | |
BR112013028531A2 (pt) | composição inseticida líquida | |
UY31059A1 (es) | Formulaciones de aminoacido n-halogenado | |
TR200902923T2 (tr) | Megestrol maddenin farmasötik olarak kararlı bir süspansiyonu. | |
CL2011001207A1 (es) | Extruidos que contienen al menos una sustancia farmacéuticamente activa en forma de agujas, tal que la relación entre el tamaño de partículas de la sustancia farmacéuticamente activa con forma de agujas y el diámetro de la cadena es de al menos 1:20; composición farmacéutica; y su uso para preparar medicamentos. | |
ITMI20052515A1 (it) | Formulazione farmaceutica per il trattamento della osteoartrite | |
MX2009005329A (es) | Composiciones farmaceuticas anticonvulsivas. | |
BR112012031471A2 (pt) | mistura para tratamento de fertilizantes | |
AR064908A1 (es) | Solucion coloidal de dexpantenol | |
MX2009003930A (es) | Novedoso cristal de (s)-(+)-2-(2-clorofenil)-2-hidroxi-etil carbamato. | |
GT200400273A (es) | Compuestos de haloalqueno, proceso para su produccion y pesticidas que los contienen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |